141 related articles for article (PubMed ID: 31718024)
1. Health Status in Long-Term Survivors of Hepatoblastoma.
Dembowska-Bagińska B; Więckowska J; Brożyna A; Święszkowska E; Ismail H; Broniszczak-Czyszek D; Stefanowicz M; Grajkowska W; Kaliciński P
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31718024
[TBL] [Abstract][Full Text] [Related]
2. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
[TBL] [Abstract][Full Text] [Related]
3. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
Dall'Igna P; Brugieres L; Christin AS; Maibach R; Casanova M; Alaggio R; de Goyet JV; Zsiros J; Morland B; Czauderna P; Childs M; Aronson DC; Branchereau S; Brock P; Perilongo G
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28921839
[TBL] [Abstract][Full Text] [Related]
4. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
6. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
[TBL] [Abstract][Full Text] [Related]
7. [Experience with hepatoblastoma treatment in small children - the use of preoperative 3D virtual analysis MeVis for liver resections].
Janek J; Bician P; Kenderessy P; Kothaj P; Novotná K; Koňarčík J; Laca Ľ; Ulianko J; Dedinská I
Rozhl Chir; 2017; 96(1):25-33. PubMed ID: 28325055
[TBL] [Abstract][Full Text] [Related]
8. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
9. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
[TBL] [Abstract][Full Text] [Related]
10. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
11. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
12. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
[TBL] [Abstract][Full Text] [Related]
15. Platinum Compound-Related Ototoxicity in Children: Long-Term Follow-Up Reveals Continuous Worsening of Hearing Loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-655. PubMed ID: 27811606
[TBL] [Abstract][Full Text] [Related]
16. Excellent Outcome Following Liver Transplantation for Hepatoblastoma Using an Extensive En Bloc Hepatectomy Technique.
Herden U; Grabhorn E; Lenhartz H; Kütemeier R; Fischer L
Transplant Proc; 2019; 51(6):1887-1891. PubMed ID: 31262438
[TBL] [Abstract][Full Text] [Related]
17. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
[TBL] [Abstract][Full Text] [Related]
18. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
Perilongo G; Brown J; Shafford E; Brock P; De Camargo B; Keeling JW; Vos A; Philips A; Pritchard J; Plaschkes J
Cancer; 2000 Oct; 89(8):1845-53. PubMed ID: 11042582
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J;
Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era.
Otte JB; de Ville de Goyet J; Reding R
Pediatr Transplant; 2005 Oct; 9(5):557-65. PubMed ID: 16176410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
